These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3301646)

  • 1. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
    Ostrand-Rosenberg S; Clements V
    Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cells.
    Ostrand-Rosenberg S; Clements V; Marr L
    Cell Immunol; 1986 Apr; 98(2):257-65. PubMed ID: 3093094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
    Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
    Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
    Ostrand-Rosenberg S; Cohn A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor.
    Ostrand-Rosenberg S; Schwartzman ML; Hecht TT; Marr L
    Cell Immunol; 1986 May; 99(2):453-60. PubMed ID: 3093106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
    Ostrand-Rosenberg S; Cohan VL
    J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo.
    Isa AM
    Transplantation; 1976 Mar; 21(3):196-8. PubMed ID: 781924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection.
    Ostrand-Rosenberg S; Clements VK; Thakur A; Cole GA
    J Immunogenet; 1989; 16(4-5):343-9. PubMed ID: 2639907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cells.
    Ostrand-Rosenberg S; Clements V; Cole G; DeCloux A; Marr L; Schwartzman M
    Cell Differ; 1984 Dec; 15(2-4):221-7. PubMed ID: 6336034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
    Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
    J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
    Bartlett PF; Fenderson BA; Edidin M
    J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to murine 402AX teratocarcinoma: regulation by H-2IA and H-3 to H-13 region genes.
    Ostrand-Rosenberg S; McCarthy C
    Immunogenetics; 1984; 19(1):77-82. PubMed ID: 6693137
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.